Pulsus Group to Establish AI-based Pharma Healthcare IT Hub in Telangana

The new hub will leverage advanced AI technologies to optimize various aspects of the pharmaceutical industry, from research and development to healthcare delivery.

Singapore-based Pulsus Group has announced plans to establish an AI-driven Pharma Healthcare IT Hub in Ameenpur, Sangareddy, Telangana.

The project, backed by an investment of INR 300 Cr, is set to create approximately 50,000 jobs, providing a substantial boost to the local economy.

Initial projections indicate that the hub will directly generate 10,000 jobs within its operations and an additional 40,000 jobs indirectly through various ancillary industries and services.

"This AI-powered hub will align with the IPC congress theme 'Role of Indian Pharma: For Global Wellbeing.' By incorporating cutting-edge artificial intelligence, we aim to streamline processes, enhance precision in drug development, and improve patient outcomes," Dr Srinubabu Gedela, CEO and MD of Pulsus Group stated.

Dr Gedela made the announcement during the 73rd IPC Congress in Hyderabad.

Pulsus Group is a health informatics and digital marketing company that specializes in publishing scientific, technical, and medical literature.

Established in 1984, Pulsus Group's primary focus is publishing peer-reviewed medical journals. Headquartered in Singapore, it also operates offices in the UK, India, and Canada.

About Pharma Healthcare IT Hub

The new hub will leverage advanced AI technologies to optimize various aspects of the pharmaceutical industry, from research and development to healthcare delivery.

This initiative is expected to advance the sector significantly while providing substantial employment opportunities for the local population.

The integration of AI aims to enhance drug development processes, ensuring greater precision and efficiency, ultimately benefiting patient care and outcomes.

Reportedly, the Telangana government, along with the Software Technology Parks of India, is offering robust support, highlighting the project's strategic significance.

Hyderabad, known as the "Bulk Drug Capital of India" and the "Vaccine Capital of the World," is a major player in the global pharmaceutical industry, contributing over 40% of the country's bulk drug manufacturing.

The city's emphasis on innovation, infrastructure development, and inclusive growth has yielded impressive results. According to the Innovation Index Rankings 2022, Telangana ranked second in manufacturing and recorded the highest per-capita income in India for 2022-23.

In a similar development, in January this year, the Telangana government collaborated with the World Economic Forum to set up its Centre for Fourth Industrial Revolution (C4IR) in the State capital.

The Centre is expected to become the world's first healthcare hub, creating jobs and fostering collaboration between the government and small- to medium-sized enterprises.